| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 12/12/2001 | EP0651789B1 Method for preventing zoster and alleviating varicella related post-herpetic neuralgia |
| 12/12/2001 | CN1326511A Systemic viral/ligand gene delivery system and gene therapy |
| 12/12/2001 | CN1326506A Use of specific hybrid promoters for controlling tissue expression |
| 12/12/2001 | CN1326505A Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
| 12/12/2001 | CN1326360A Use of enterobacterium protein OMPA for specific targeting towards antigen-presening cells |
| 12/12/2001 | CN1325729A Application of R-phycoerythrin in preparing photosensitive medicine for phototherapy of tumor |
| 12/12/2001 | CN1325723A Chinese medicine for treating diabetes and its preparing process |
| 12/12/2001 | CN1325722A Chinese medicine for treating diabetes and neurovascular lesion of both feet and its preparing process |
| 12/12/2001 | CN1325720A Medicinal composition for treating tuberculosis and its preparing process |
| 12/12/2001 | CN1325719A Antalgesic liquid for cervical dilatation |
| 12/12/2001 | CN1325718A Freeze dried compound queen bee powder |
| 12/12/2001 | CN1325717A Health-care food prepared from extracts of animals bone marrow and Chinese-medicinal materials |
| 12/12/2001 | CN1325710A Tianjian capsule and its preparing process |
| 12/12/2001 | CN1325708A Multipurpose anticancer ointment |
| 12/12/2001 | CN1325706A Liquid medicine for baby to invigorate function of spleen and promote secretion of body fluid |
| 12/12/2001 | CN1325699A Oral liquid 'Rongshuanling' |
| 12/12/2001 | CN1325688A Process for preparing high-activity soft capsules of forest frog's oviduct fat |
| 12/12/2001 | CN1325687A Medicine for treating gastric ulcer and duodenal ulcer |
| 12/12/2001 | CN1325632A Process for preparing enzymolyzed silkworm product and its usage |
| 12/12/2001 | CN1075948C External-used medicine for treating protrusion of intervertebral disc |
| 12/11/2001 | US6330472 Prophylactic and therapeutic treatment of the ductal epithelium for a mammary gland for cancer |
| 12/11/2001 | US6329352 Method and composition for treating sleep apnea |
| 12/11/2001 | US6329336 Glue and crosslinking agent using albumin |
| 12/11/2001 | US6329199 A vector resistant to inactivation by human serum, produced in cells containing retroviral envelope protein sequence from feline endogenous virus, long terminal repeats sequences, signal and packaging sequences; for effective gene therapy |
| 12/11/2001 | US6329002 Food for inhibiting infection and treating gastritis, gastric and duodenal ulcers |
| 12/11/2001 | US6329000 Extract of pine needle and the use thereof |
| 12/11/2001 | US6328971 MAGE-1 derived nona peptides, and compositions thereof |
| 12/11/2001 | US6328961 For therapy of gram-positive bacterial infections |
| 12/11/2001 | US6328960 Administering to transplant recipient mesenchymal stem cells in an amount effective to reduce an immune response of effector cells against an alloantigen to effector cells |
| 12/11/2001 | US6328959 Intestinal hydrogen removal using hydrogen-metabolizing microbes |
| 12/11/2001 | US6328957 Heat shock proteins and the treatment of tumors |
| 12/11/2001 | US6328762 Prosthetic grafts |
| 12/11/2001 | CA2066053C Recombinant retroviruses delivering vector constructs to target cells |
| 12/06/2001 | WO2001092877A2 Method of identifying and/or isolating stem cells |
| 12/06/2001 | WO2001092581A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 12/06/2001 | WO2001092551A2 Duplexed parvovirus vectors |
| 12/06/2001 | WO2001092549A2 Method and composition for targeting an adenoviral vector |
| 12/06/2001 | WO2001092547A2 Modified bovine adenovirus having altered tropism |
| 12/06/2001 | WO2001092526A1 Human kcnq5 potassium channel, methods and compositions thereof |
| 12/06/2001 | WO2001092481A1 Method of preparing small hepatocytes preservable in freeze-dried state and method of preserving the same in freeze-dried state |
| 12/06/2001 | WO2001092480A1 Method of forming vertebrate pancreas in vitro |
| 12/06/2001 | WO2001092479A2 Method to determine the differentiation potential of a target cell |
| 12/06/2001 | WO2001092477A2 Three-dimensional skin model |
| 12/06/2001 | WO2001092474A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof |
| 12/06/2001 | WO2001092473A2 Method for cultivating a cartilage replacement and a biomatrix produced according to this method |
| 12/06/2001 | WO2001092470A2 Dna expression vectors and methods of use |
| 12/06/2001 | WO2001092322A1 Use of collagen of aquatic origin for producing support designed for tissue engineering, and resulting supports and biomaterials |
| 12/06/2001 | WO2001092320A2 Use a high-molecular-weight extracellular haemoglobin as blood substitute |
| 12/06/2001 | WO2001092299A2 Adenovirus particles with mutagenized fiber proteins |
| 12/06/2001 | WO2001091820A1 Method for producing a bio-artificial transplant |
| 12/06/2001 | WO2001091803A2 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 12/06/2001 | WO2001091801A2 Methods of transducing neural cells using lentivirus vectors |
| 12/06/2001 | WO2001091791A2 Immune-stimulating bacterial cell wall extracts |
| 12/06/2001 | WO2001091789A2 Combination of a mutant herpes virus and a chemotherapeutic agent for the treatment of cancer |
| 12/06/2001 | WO2001091787A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | WO2001091783A2 Methods and compositions for producing a neurosalutary effect in a subject |
| 12/06/2001 | WO2001091775A2 Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity |
| 12/06/2001 | WO2001091771A2 Compositions for treating back and leg discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| 12/06/2001 | WO2001091766A2 Compositions for treating hand and wrist discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| 12/06/2001 | WO2001091763A2 Extracts from spermatophyte plants with antitumor activity |
| 12/06/2001 | WO2001091711A1 Use of exogenous lactic bacteria strain against actinomyces naeslundii related diseases |
| 12/06/2001 | WO2001091671A1 Xenograft heart valves |
| 12/06/2001 | WO2001091588A1 Primary composition containing a lipophilic bioactive compound |
| 12/06/2001 | WO2001049717A3 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity |
| 12/06/2001 | WO2001042421A3 Long-term cell culture compositions and genetically modified animals derived therefrom |
| 12/06/2001 | WO2001038495A3 Method for producing a thrombocyte preparation and a thrombocyte preparation |
| 12/06/2001 | WO2001030381A3 Use of csf-1 inhibitors |
| 12/06/2001 | WO2001026604B1 Hair and scalp treatment method and recipes for application of this method |
| 12/06/2001 | WO2001016345A3 Sequence-specific dna recombination in eukaryotic cells |
| 12/06/2001 | WO2001014416A3 Synthetic papillomavirus genes optimized for expression in human cells |
| 12/06/2001 | WO2001012775A8 25 human secreted proteins |
| 12/06/2001 | WO2000077233A3 Complement-resistant non-mammalian dna viruses and uses thereof |
| 12/06/2001 | WO2000038517A9 Methods for reducing adverse side effects associated with cellular transplantation |
| 12/06/2001 | US20010049827 Method for providing pathogen-free porcine tissue suitable for human transplantation |
| 12/06/2001 | US20010049145 Hepatitis B virus vectors for gene therapy |
| 12/06/2001 | US20010049144 Genetically engineering a primate for expression of a desired gene, comprising introducing into the primate a transgene of a Rous Sarcoma Virus promoter (RSV) and a nucleic acid sequence heterologous to said RSV promoter; gene therapy |
| 12/06/2001 | US20010049142 A rapid, simple-to-use method to differentiate nondividing cells by fusing two different cells and then purifying them without antibiotic or metabolic selection; kits with two nontoxic dyes and instructions; antitumor agents |
| 12/06/2001 | US20010049139 Transplantation of hematopoietic stem cells to repopulate functional hepatocytes; in vitro cell culture of regenerating hepatocytes generated from a human cell population; screening for genetic sequences using hybridization of an RNA probe |
| 12/06/2001 | US20010049138 Disrupting the cell membranes of the tissue sample; denaturing intracellular proteins within the cells and removing the denatured proteins while preserving the extracellular matrix; nerve grafting |
| 12/06/2001 | US20010049136 Deletion of: all or part of the E1A regions, the E1B region coding for the early proteins, E2 or E4 regions, the E1a region and encapsidation region; gene therapy |
| 12/06/2001 | US20010049130 Carrier for pancreatic cells for transplantation into an animal body is formed with a lateral extent much greater than its thickness to enhance its diffusional capability; enhanced hormonal response to stimuli as in blood sugar levels |
| 12/06/2001 | US20010049115 Vitro model for gastrointestinal inflammation |
| 12/06/2001 | US20010048949 Isolated bladder submucosa for tissue reconstruction |
| 12/06/2001 | US20010048948 Intestine health; immunology; mixture containing whey |
| 12/06/2001 | US20010048930 Incubation lymphocytes with antigen; complexing |
| 12/06/2001 | US20010048921 Forming chimeric bone marrow |
| 12/06/2001 | US20010048920 Reovirus for the treatment of neoplasia |
| 12/06/2001 | US20010048919 Virus clearance of neoplastic cells from mixed cellular compositions |
| 12/06/2001 | US20010048917 Skin equivalent and methods of forming and using same |
| 12/06/2001 | CA2411666A1 Methods and compositions for producing a neurosalutary effect in a subject |
| 12/06/2001 | CA2411404A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 12/06/2001 | CA2410981A1 Adenovirus particles with mutagenized fiber proteins |
| 12/06/2001 | CA2410944A1 Cartilage replacement and method for its production |
| 12/06/2001 | CA2410903A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | CA2410736A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof |
| 12/06/2001 | CA2410684A1 Method to determine the differentiation potential of a target cell |
| 12/06/2001 | CA2410665A1 Modified bovine adenovirus having altered tropism |
| 12/06/2001 | CA2410591A1 Use of exogenous lactic bacteria strain against actinomyces naeslundii related diseases |
| 12/06/2001 | CA2410515A1 Method of identifying and/or isolating stem cells |
| 12/06/2001 | CA2410489A1 Human kcnq5 potassium channel, methods and compositions thereof |